Audit flagged chronic inspection failures, manpower gaps, and weak enforcement — warnings that went unheeded until 22 children died in Madhya Pradesh.

A year before the deaths of over 20 children in Madhya Pradesh’s Chhindwara district from contaminated cough syrup, the Comptroller and Auditor General of India (CAG) had already sounded the alarm on glaring lapses in Tamil Nadu’s drug regulatory system — the state where the fatal syrup was manufactured.
Between 2016-17 and 2020-21, Tamil Nadu’s drug inspectors consistently failed to meet targets, conducting only 61% of planned inspections and collecting barely half the required samples for quality testing, the CAG report revealed. Despite the warnings, systemic gaps in oversight and enforcement persisted — gaps that experts now say proved deadly.

In the aftermath of the Chhindwara tragedy, the prescribing doctor and three local drug inspectors were suspended, while the Centre ordered “risk-based inspections” at 19 pharmaceutical units across six states to identify regulatory weaknesses.
Sresan Pharmaceuticals, the Tamil Nadu-based manufacturer of Coldrif cough syrup linked to the deaths, received a show-cause notice for serious violations — but only after the Madhya Pradesh drug regulator pressed its southern counterpart to act. “Had the Tamil Nadu authorities enforced the CAG’s recommendations and tightened their inspection protocols, this tragedy might have been prevented,” a senior official said.
The CAG’s performance audit, submitted to the Tamil Nadu government on August 1, 2024, and tabled in the Assembly that December, painted a bleak picture of the state’s public health oversight.
From 2016 to 2021, drug inspectors repeatedly missed targets: in 2017-18, only 60,495 of the targeted 1,00,800 inspections were carried out — a 40% shortfall. Even in 2020-21, inspections lagged by nearly 38%.
The same pattern extended to sample collection. In 2020-21, for instance, just 8,604 of 18,816 required samples were tested — a 54% deficit.

Compounding the crisis was a severe manpower shortage: the drug control department operated with only 344 staff against a sanctioned strength of 488, leaving a 32% vacancy rate.
Officials warn these persistent failures are not isolated to one state. “Drugs manufactured in Tamil Nadu are distributed across India. Weak local oversight poses a national risk,” one official noted.
The revelations now sharpen the focus on regulatory accountability — and whether India’s drug safety framework can prevent another tragedy born not of negligence, but of warnings ignored.

Sports Diplomacy & Regional Pride

Constitutional Reforms & Accountability

Seeds, Food Security & Agriculture

India–EU Green Transition Partnership

Governance Reform & Electoral Integrity

‘I live freely, but cautiously in Delhi’: Sheikh Hasina vows not to leave India, warns of Bangladesh poll boycott

Haryana youth’s Russian dream ends in drone strike death

Punjab rehab scam unmasked as doctor ran 22 centres, faked patients and sold recovery drugs in black market

‘Modi turned Yamuna into a swimming pool drama’: Rahul Gandhi tears into PM at Bihar rally

‘Lalu wants his son as CM, Sonia hers as PM’: Amit Shah fires dynastic salvo in Bihar rally

Sports Diplomacy & Regional Pride

Constitutional Reforms & Accountability

Seeds, Food Security & Agriculture

India–EU Green Transition Partnership

Governance Reform & Electoral Integrity

‘I live freely, but cautiously in Delhi’: Sheikh Hasina vows not to leave India, warns of Bangladesh poll boycott

Haryana youth’s Russian dream ends in drone strike death

Punjab rehab scam unmasked as doctor ran 22 centres, faked patients and sold recovery drugs in black market

‘Modi turned Yamuna into a swimming pool drama’: Rahul Gandhi tears into PM at Bihar rally

‘Lalu wants his son as CM, Sonia hers as PM’: Amit Shah fires dynastic salvo in Bihar rally
Copyright© educationpost.in 2024 All Rights Reserved.
Designed and Developed by @Pyndertech